| Breakdown | TTM | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 104.68B | 102.56B | 101.89B | 99.46B | 110.67B | 112.94B |
| Gross Profit | 26.18B | 25.38B | 24.99B | 24.81B | 28.89B | 29.97B |
| EBITDA | 3.97B | 2.76B | 3.96B | 3.57B | 3.89B | 5.02B |
| Net Income | -806.00M | -2.62B | 451.00M | 205.00M | 368.00M | 878.00M |
Balance Sheet | ||||||
| Total Assets | 56.11B | 55.58B | 58.19B | 54.26B | 49.62B | 51.15B |
| Cash, Cash Equivalents and Short-Term Investments | 6.29B | 5.75B | 6.03B | 5.35B | 6.15B | 7.72B |
| Total Debt | 11.38B | 15.31B | 15.58B | 10.42B | 5.29B | 5.48B |
| Total Liabilities | 29.48B | 29.61B | 29.32B | 25.62B | 20.81B | 22.41B |
| Stockholders Equity | 26.62B | 25.97B | 28.86B | 28.64B | 28.81B | 28.73B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.71B | -1.86B | -4.24B | -603.00M | 1.41B |
| Operating Cash Flow | 0.00 | 3.32B | 1.63B | 1.93B | 2.25B | 5.69B |
| Investing Cash Flow | 0.00 | -2.40B | -3.54B | -7.13B | -3.11B | -3.60B |
| Financing Cash Flow | 0.00 | -1.20B | 2.60B | 4.40B | -699.00M | -1.55B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥113.61B | 16.52 | ― | 1.92% | 2.30% | 26.52% | |
76 Outperform | ¥154.20B | 15.86 | ― | 1.64% | 10.13% | 23.77% | |
72 Outperform | ¥92.12B | 10.82 | ― | 1.47% | 7.75% | -1.68% | |
71 Outperform | ¥74.17B | 11.40 | ― | 1.34% | 20.50% | 10.77% | |
66 Neutral | ¥31.93B | 14.62 | ― | 2.22% | 7.94% | -8.55% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
51 Neutral | ¥12.62B | 29.59 | ― | 2.32% | 2.43% | 50.53% |